My Size (MYSZ) AI Stock Analysis

• Market Cap: $2.65M
• Dividend Yield: N/A
• Average Volume (3M): 435.95K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.69
• Revenue Growth: -22.01%
• EPS Growth: 93.14%
• Country: US
• Employees: 13
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): -0.40
• Shares Outstanding: 3,848,979
• 10 Day Avg. Volume: 54,532
• 30 Day Avg. Volume: 435,951
• PEG Ratio: 0.01
• Price to Book (P/B): 0.56
• Price to Sales (P/S): 0.47
• P/FCF Ratio: -1.25
• Enterprise Value/Market Cap: -0.43
• Enterprise Value/Revenue: -0.15
• Enterprise Value/Gross Profit: -0.39
• Enterprise Value/Ebitda: 0.30
• 1Y Price Target: $3.00
• Price Target Upside: 328.57% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: $0.77 ▲(10.14% Upside)

The score is held back primarily by weak financial performance—large losses and ongoing cash burn outweigh improving revenue and a low-leverage balance sheet. Technicals are mixed with modest near-term improvement but a weak longer-term trend, while valuation remains constrained by a negative P/E. A positive corporate update on strategy and revenue/cash outlook provides some offset but does not fully counter current profitability and cash-flow risks.

Positive Factors

Revenue Growth and Gross Margin Stability

Consistent top-line expansion with a steady ~39% gross margin indicates product-market fit for My Size’s measurement licensing. Durable revenue growth at the gross-margin level supports operating leverage as sales scale, improving the pathway to sustainable cash generation over the medium term.

Low Financial Leverage

Very low leverage provides balance-sheet flexibility, reducing bankruptcy and interest burden risks. This structural cushion allows management to prioritize execution and disciplined scaling without immediate debt servicing pressure, aiding resilience during the multi-quarter transition to profitability.

Unified Platform Strategy & Management Focus

Management’s shift to an integrated, four-business platform and explicit cross-sell strategy is a structural change that can raise revenue per customer and improve lifetime value. Coupled with stated focus on operating breakeven and disciplined capital allocation, this increases the chance of sustainable margin expansion if execution holds.

Negative Factors

Ongoing Negative Cash Flow

Persistently negative operating and free cash flow forces reliance on external financing and limits reinvestment capacity. Until operations generate positive cash, the company faces structural liquidity and dilution risks that constrain long-term strategic options and could impede scaling initiatives.

Deep Losses and Weak Profitability

Very negative margins and returns show the current business does not cover its operating cost base. Even with revenue growth, the company must materially improve operating leverage or cut structural costs; otherwise sustained losses will erode shareholders' equity and delay a durable path to profitability.

Small Scale and Execution Risk

A small revenue base and a 13-person workforce indicate limited internal capacity to execute large enterprise integrations, scale sales, or deliver cross-selling across multiple product lines. This structural constraint raises execution risk and could slow the company’s ability to convert strategy into sustained revenue and margin gains.

My Size Business Overview & Revenue Model

Company Description

My Size, Inc. develops and commercializes mobile device measurement solutions for e-commerce fashion/apparel, shipping/parcel, and do it yourself industries in Israel. It offers MySizeID, an application that enables consumers to create an online profile of their personal measurements to get the right fit; BoxSize, a parcel measurement application that allows customers to measure the size of their parcel with their smartphone, calculate shipping costs, and arrange for a convenient pick-up time for the package; SizeUp app, which allows users to utilize their smartphone as a tape measure; and SizeIT, a smart measuring tape SDK that provides users with the ability to instantly and accurately measure objects with a quick movement of their mobile device. The company was formerly known as Knowledgetree Ventures, Inc. and changed its name to My Size, Inc. in January 2014. My Size, Inc. was incorporated in 1999 and is headquartered in Airport City, Israel.

How the Company Makes Money

My Size generates revenue primarily through the licensing of its measurement technology to e-commerce retailers and brands. By integrating My Size's solutions into their platforms, retailers can offer enhanced sizing tools to their customers, leading to increased conversion rates and reduced product returns. The company also earns revenue through partnerships with retail chains and online marketplaces, where it provides its software solutions as part of a broader customer engagement strategy. Additionally, My Size may explore revenue streams through subscription models for its software services and potential future expansions into related markets such as augmented reality and virtual fitting rooms.

My Size Financial Statement Overview

Summary

Revenue is growing (TTM $7.5M, +10.8%) and gross margin is steady (~39%), but profitability and cash generation remain the core weaknesses: net margin is deeply negative (~-47%) and TTM operating/free cash flow are meaningfully negative (~-$3.5M). Balance sheet leverage is low (debt-to-equity ~0.13), yet losses are eroding returns (ROE ~-52%).

Income Statement

TTM (Trailing-Twelve-Months) revenue rose to $7.5M (up 10.8%), showing the top line is still expanding, and gross margin is a reasonably steady ~39%. However, profitability remains very weak: EBIT and net income are deeply negative in TTM (net margin about -47%), and while losses improved materially versus 2022–2023, the company has not yet demonstrated a path to break-even.

Balance Sheet

Leverage is low, with debt modest relative to equity (TTM debt-to-equity ~0.13) and equity of roughly $7.3M supporting a ~$11.7M asset base, which provides some financial flexibility. The key weakness is ongoing value erosion from losses, reflected in consistently negative returns on equity (TTM about -52%), meaning the balance sheet could weaken over time if profitability does not improve.

Cash Flow

Cash generation is the major pressure point: TTM operating cash flow and free cash flow are both meaningfully negative (about -$3.5M), consistent with a business still funding operations via external capital rather than internal cash. Cash burn has improved versus 2022–2023, but free cash flow remains negative and closely tracks net losses, highlighting continued financing risk until operating performance turns sustainably positive.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	7.51M	8.26M	7.00M	4.46M	131.00K	142.00K
Gross Profit	2.90M	3.32M	2.73M	634.00K	131.00K	140.00K
EBITDA	-3.82M	-3.60M	-5.10M	-7.92M	-10.44M	-6.07M
Net Income	-3.56M	-4.00M	-6.38M	-8.31M	-10.52M	-6.17M
Balance Sheet
Total Assets	11.65M	10.06M	8.99M	9.73M	12.56M	3.57M
Cash, Cash Equivalents and Short-Term Investments	4.49M	4.88M	2.19M	2.10M	10.67M	1.69M
Total Debt	946.00K	276.00K	694.00K	998.00K	611.00K	708.00K
Total Liabilities	4.36M	3.15M	4.26M	5.19M	1.70M	1.49M
Stockholders Equity	7.30M	6.91M	4.74M	4.54M	10.86M	2.08M
Cash Flow
Free Cash Flow	-3.53M	-3.10M	-6.11M	-7.32M	-7.32M	-5.72M
Operating Cash Flow	-3.50M	-3.09M	-6.11M	-7.29M	-7.30M	-5.68M
Investing Cash Flow	-211.94K	53.00K	-7.00K	-993.00K	161.00K	-211.00K
Financing Cash Flow	5.80M	5.59M	6.13M	-67.00K	16.29M	6.09M

My Size Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.70
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MYSZ, the sentiment is Negative. The current price of 0.7 is below the 20-day moving average (MA) of 0.84, below the 50-day MA of 0.87, and below the 200-day MA of 1.14, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 34.57 is Neutral, neither overbought nor oversold. The STOCH value of 9.65 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MYSZ.

My Size Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
MYSZ	49 Neutral	$2.65M	-0.49	-60.58%	―	-22.01%	93.14%
BIYA	49 Neutral	$4.32M	-0.38	-41.11%	―	―	―
ULY	47 Neutral	$4.32M	-0.10	―	―	-17.95%	-124.63%
TGL	41 Neutral	$7.61M	-0.04	-269.14%	―	-73.83%	98.11%
FRGT	40 Underperform	$1.85M	>-0.01	―	―	-19.53%	92.37%

My Size Corporate Events

MySize CEO Outlines Platform Strategy and Revenue Outlook

On December 29, 2025, MySize issued a CEO letter to shareholders outlining how the company has evolved into a unified platform operating four revenue-generating businesses in AI-driven sizing, commerce enablement, resale infrastructure, and data intelligence for the global fashion industry. The company reported that, based on current run-rate and contracted customers, it expects to close 2025 with approximately $10 million in revenue and around $4 million in year-end cash, and indicated that its existing resources fund its current operating plan, shifting management’s focus toward execution, integration, and disciplined scaling. The letter also highlighted an expected revenue trajectory toward about $15 million in 2026, driven largely by expansion with existing customers and cross-selling across its integrated businesses, with management emphasizing progress toward operating breakeven, growing operating leverage, and a disciplined approach to capital allocation and potential strategic opportunities after several challenging early years as a pre-revenue public company.

The most recent analyst rating on (MYSZ) stock is a Hold with a $0.99 price target. To see the full list of analyst forecasts on My Size stock, see the MYSZ Stock Forecast page.

My Size Grants Performance-Based Restricted Stock to Executives

On December 15, 2025, My Size, Inc. granted restricted stock awards to its executive officers under its 2017 Equity Incentive Plan, allocating varying amounts of performance-based and time-based shares to the CEO, chief growth officer, chief product and operating officer, and chief financial officer, with a portion of the chief growth officer’s time-based award vesting immediately. The remaining time-based awards are scheduled to vest in three equal annual installments on January 1, 2026, 2027 and 2028, while the performance-based awards will vest only if specified profit and business targets are met, aligning executive compensation more closely with long-term company performance and retention objectives.

The most recent analyst rating on (MYSZ) stock is a Hold with a $0.99 price target. To see the full list of analyst forecasts on My Size stock, see the MYSZ Stock Forecast page.